Table 2. Characteristics of transplant donors and recipients at transplantation, according to Toxoplasma serologic status, Europe, 2010–2014*.
| Serologic status of donor/recipient† |
Prophylaxis,
no. (%) |
Graft type, no. | Survived 6 mo, no. (%) |
Wks between diagnosis and graft, mean ± SE | |||
|---|---|---|---|---|---|---|---|
| Liver |
Kidney |
Heart |
HSC |
||||
| Positive/positive, n = 9‡ | 5 (56) | 2 | 0 | 1 | 6 | 3 (33) | 21 ± 9 |
| Positive/negative, n = 11§ | 4 (36) | 3 | 4 | 4 | 0 | 9 (82) | 309 ± 275 |
| Negative/positive, n = 36¶ | 12 (33) | 0 | 0 | 1 | 35 | 12 (33) | 15 ± 3 |
| Negative/negative, n = 14 |
9 (64) |
2 |
2 |
5 |
5 |
11 (79) |
123 ± 31 |
| p value | 0.1975 | NA | NA | NA | NA | <0.01 (0.0029) | <0.05 |
*HSC, hematopoietic stem cell; NA, not applicable. †Missing data for 17 patients. ‡2 liver transplant recipients died. §Group in which solid organ transplant patients are most at risk for toxoplasmosis. ¶Group in which HSC transplant patients are most at risk for toxoplasmosis.